Conditional inactivation of TACE by a Sox9 promoter leads to osteoporosis and increased granulopoiesis via dysregulation of IL-17 and G-CSF.
about
A Disintegrin and Metalloprotease 17 in the Cardiovascular and Central Nervous SystemsArid5a cooperates with Sox9 to stimulate chondrocyte-specific transcriptionTissue inhibitor of metalloproteinase-3 (TIMP-3) regulates hematopoiesis and bone formation in vivo.ADAM17 deletion in thymic epithelial cells alters aire expression without affecting T cell developmental progressionADAM-17: the enzyme that does it all.Stress-induced production of chemokines by hair follicles regulates the trafficking of dendritic cells in skin.Critical role of the disintegrin metalloprotease ADAM17 for intestinal inflammation and regeneration in miceConditional inactivation of TNFα-converting enzyme in chondrocytes results in an elongated growth plate and shorter long bones.The proprotein convertase subtilisin/kexin furinA regulates zebrafish host response against Mycobacterium marinum.Dysbiosis and Staphylococcus aureus Colonization Drives Inflammation in Atopic Dermatitis.Genetic mouse models for bone studies--strengths and limitationsADAM17 controls endochondral ossification by regulating terminal differentiation of chondrocytes.Proteolytic factors in exosomes.Microarray profile of gene expression during osteoclast differentiation in modelled microgravity.Regulation of long-term repopulating hematopoietic stem cells by EPCR/PAR1 signalingEctodomain shedding of FLT3 ligand is mediated by TNF-alpha converting enzyme.Species specificity of ADAM10 and ADAM17 proteins in interleukin-6 (IL-6) trans-signaling and novel role of ADAM10 in inducible IL-6 receptor shedding.Considerations on inhibition approaches for proinflammatory functions of ADAM proteases.
P2860
Q28072451-6D19C824-97A3-4345-8ACF-05CEF31F7676Q28513326-352B7CEC-2272-48B6-95BD-7B32B27999C2Q33717003-7F21B772-C9B0-4CA2-ADF1-8C4C3A625DF7Q33728091-C009F5DA-222C-4C85-B755-5B3D43097D95Q33737421-6063A601-F5F8-4813-941C-89B78DC5FDDEQ33970584-698B2A0C-0A20-41B5-BC0A-E44AC97C6229Q34044458-EEE067DF-2281-4366-8BE9-3CAE7D4616BDQ34563518-6009A404-6B7F-49AB-A928-684C1FEDBCF9Q35187534-F289682A-DC37-43E1-A87A-7F14E20468EFQ35532126-ABB5863C-F3DA-490E-99F1-569558A17516Q35902980-0B721EFE-64A7-4DCD-814E-96FF25C24536Q37122908-2A5E7C37-335B-431E-974A-8F676FC21710Q38092801-49FE4D09-7806-4E83-82A3-91044ADDE712Q38341566-C233A881-804E-4B4B-B9BA-F3684BCA44A9Q38755609-9354276A-1F5D-401E-886E-4CD0F910E58DQ42137709-8EE6E10D-93C6-4867-9748-1290160CBCB6Q42722712-AFC2BD31-CBF7-4E68-9FA2-73B162671927Q50495797-B57737B9-0B73-4B11-9DBD-8F79F32372EA
P2860
Conditional inactivation of TACE by a Sox9 promoter leads to osteoporosis and increased granulopoiesis via dysregulation of IL-17 and G-CSF.
description
2009 nî lūn-bûn
@nan
2009 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Conditional inactivation of TA ...... regulation of IL-17 and G-CSF.
@ast
Conditional inactivation of TA ...... regulation of IL-17 and G-CSF.
@en
Conditional inactivation of TA ...... regulation of IL-17 and G-CSF.
@nl
type
label
Conditional inactivation of TA ...... regulation of IL-17 and G-CSF.
@ast
Conditional inactivation of TA ...... regulation of IL-17 and G-CSF.
@en
Conditional inactivation of TA ...... regulation of IL-17 and G-CSF.
@nl
prefLabel
Conditional inactivation of TA ...... regulation of IL-17 and G-CSF.
@ast
Conditional inactivation of TA ...... regulation of IL-17 and G-CSF.
@en
Conditional inactivation of TA ...... regulation of IL-17 and G-CSF.
@nl
P2093
P2860
P356
P1476
Conditional inactivation of TA ...... sregulation of IL-17 and G-CSF
@en
P2093
Carl P Blobel
Haruhiko Akiyama
Hideo Morioka
Hironari Takaishi
Kana Miyamoto
Takashi Nakamura
Takeshi Miyamoto
Tokuhiro Kimura
Yoshiaki Toyama
P2860
P304
P356
10.4049/JIMMUNOL.0802491
P407
P577
2009-02-01T00:00:00Z